More on PFSA
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.05 |
|
|||
| Open | $3.51 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.18 | ||||
| Day Low | $2.39 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 68,053,314 | ||||
- Here’s What Investors Are Watching, Including $20 Price Target Bombshell
- Profusa receives ISO 13485 certification decision for Lumee platform
- Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
- Profusa regains Nasdaq compliance, faces one-year monitoring period
- Profusa, Inc. Receives Nasdaq Compliance Determination
- Profusa regains Nasdaq compliance after reverse stock split issue
- Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
- Profusa reports Q2 2026 loss, advances G3 Vision Labs deal
- Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
- Profusa announces 1-for-4 reverse stock split effective Aug. 17
Entities mentioned with pfsa
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Bitcoin | View Related Stories »
- S1 | View Related Stories »
- FDA | View Related Stories »
- SPAC | View Related Stories »
- Show More...
